Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/4782
Title: 2018 in review: gynecologic cancer insights
Authors: Melo, Andreia Cristina de
Paulino, Eduardo
Calabrich, Aknar Freire de Carvalho
Guimarães, Andréa Paiva Gadelha
Freitas, Daniela
Maluf, Fernando Cotait
Faroni, Lilian Dantonino
Vieira, Marcelo de Andrade
Ribeiro, Reitan
Rodrigues, Angélica Nogueira
Keywords: Revisão
Review
Neoplasias dos Genitais Femininos
Genital Neoplasms Female
Issue Date: 2018
Publisher: Braz J Oncol.
Citation: MELO, Andreia Cristina de et al. 2018 in review: gynecologic cancer insights. Braz J Oncol., p. 1-5, dec. 2018.
Abstract: Gynecologic cancers constitute an important burden of disease around the world. Estimates from GLOBOCAN 2018 reveals approximately 1,247,300 incident casesand 596,000 related deaths of cancers of the uterine cervix, corpus uteri, and ovarian, annually around the world. In 2018 lots of promising results to improve disease control have been presented at international gynecological cancer meetings. The current review highlights some of the top gynecologic cancer news of 2018, including the new standard of care for BRCAmutant ovarian cancer patients with maintenance olaparib in first line, benefit of bevacizumab rechallenge for relapsed ovarian cancer patients, and the unexpected results of worse overall survival with minimally invasive surgery in early cervical cancer, among others.
Description: p. 1-5.: tab. p&b.
URI: http://sr-vmlxaph03:8080/jspui/handle/123456789/4782
ISSN: 2526-8732
Appears in Collections:Artigos de Periódicos da área de Ginecologia

Files in This Item:
File Description SizeFormat 
2018 in review gynecologic cancer insights..pdf106.96 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.